Literature DB >> 6276011

Harvey and Kirsten sarcoma viruses promote the growth and differentiation of erythroid precursor cells in vitro.

W D Hankins, E M Scolnick.   

Abstract

Harvey and Kirsten murine sarcoma viruses have previously been shown to transform fibroblastic cells in culture, and type C virus pseudotypes of these viruses cause erythroleukemia in susceptible mice. We report a cell culture assay for quantitating the growth-promoting effect of Harvey and Kirsten viruses on erythroid cells. Murine hemopoietic cells were infected in vitro with Harvey or Kirsten sarcoma virus, and then cultured in methylcellulose in the presence of relatively low concentrations of erythropoietin. Under these conditions, large colonies of erythroid cells form in the semi-solid culture media 6 to 8 days after infection. The induction of erythroid bursts was not caused by the murine type C helper viruses used to pseudotype either Ha-MuSV or Ki-MuSV, or by media from cells carrying the Ki-MuSV and Ha-MuSV genomes. Induction of the erythroid colonies is under genetic control at the Fv1 susceptibility locus, but not at the Fv2 susceptibility locus. A striking feature of the erythroid colonies induced by the Harvey and Kirsten viruses was that they not only proliferated to large size but also differentiated along the erythroid lineage and synthesized hemoglobin. The results indicate that Ha-MuSV and Ki-MuSV can induce proliferation of erythroid precursor cells apparently without interfering with the differentiation program of the cells. The relation between the growth-promotion effect of these viruses on erythroid precursor cells and their ability to induce erythroleukemia is discussed.

Entities:  

Mesh:

Year:  1981        PMID: 6276011     DOI: 10.1016/0092-8674(81)90036-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  25 in total

1.  Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.

Authors:  M C Rouyez; C Boucheron; S Gisselbrecht; I Dusanter-Fourt; F Porteu
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  The myeloproliferative sarcoma virus causes transformation or erythroid progenitor cells in vitro.

Authors:  W D Hankins; T A Kost; I B Pragnell
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

3.  raf/myc-infected erythroid cells are restricted in their ability to terminally differentiate.

Authors:  S P Klinken; U R Rapp; H C Morse
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  P21 v-ras inhibits induction of c-myc and c-fos expression by platelet-derived growth factor.

Authors:  J N Zullo; D V Faller
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

Review 5.  Tumor viruses and early mouse embryos.

Authors:  F Kelly; H Condamine
Journal:  Biochim Biophys Acta       Date:  1982-04-29

6.  Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.

Authors:  T Nakagawa; M Mabry; A de Bustros; J N Ihle; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Hematopoietic cell transformation by a murine recombinant retrovirus containing the src gene of Rous sarcoma virus.

Authors:  J H Pierce; S A Aaronson; S M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Differential expression of the ras gene family in mice.

Authors:  J Leon; I Guerrero; A Pellicer
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

9.  Action of temperature-sensitive mutants of myeloproliferative sarcoma virus suggests that fibroblast-transforming and hematopoietic transforming viral properties are related.

Authors:  W Ostertag; M Freshney; K Vehmeyer; C Jasmin; G Rutter
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

10.  src- and fps-containing avian sarcoma viruses transform chicken erythroid cells.

Authors:  P Kahn; B Adkins; H Beug; T Graf
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.